← All trials
NCT01882010
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2013
- Primary completion
- Jan 1, 2016
- Completion date
- Jan 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 37
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of NebraskaLead sponsor
- University of NebraskaOverall official - principal investigator
- University of NebraskaSponsor investigator
- SanofiCollaborator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- UNeMedCollaborator
- Nebraska Neuroscience AllianceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.